Skip to main content

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

FARMALARM: Integral communication platform and intelligent clinical follow-up

IP: Marc Ribó Jacobi
Collaborators: -
Funding agency: Fundació Barcelona Mobile World Capital Foundation
Funding: 2000
Reference: FBMWCF/COLLIDER/2019/RIBO
Duration: 21/06/2019 - 19/03/2020

App for Smartphones to induce healty lifestyle modification and therapeutic compliance monitoring in stroke secondary prevention in multiple centers across Catalunya

IP: Marc Ribó Jacobi
Collaborators: Carlos Molina Cateriano, Estefania Montiel
Funding agency: Fundació La Marató de TV3
Funding: 149990
Reference: 20172810
Duration: 01/01/2018 - 31/12/2021

Computarized Tomography Perfusion to characterize lack of clinical improvement AFTer RECanalization in acute ischemic stroke (CTP_AFT_REC)

IP: Marta Aurora Rubiera Del Fueyo
Collaborators: Marc Ribó Jacobi, Computarized Tomography Perfusion to characterize lack of clinical improvement AFTer RECanalization in acute ischemic stroke (CT, Alejandro Tomasello Weitz
Funding agency: Fundació La Marató de TV3
Funding: 199955
Reference: 20173210
Duration: 01/01/2018 - 31/12/2020

Malalties Neurovasculars (GRC)

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Malalties Neurovasculars (GRC), José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Malalties Neurovasculars (GRC), Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 48000
Reference: 2014 SGR 686
Duration: 01/01/2014 - 31/12/2016

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Jordi Francesc Llados Segura

Jordi Francesc Llados Segura

Postdoctoral researcher
Rheumatology
Read more
Meritxell Ibernon Vilaró

Meritxell Ibernon Vilaró

Kidney Physiopathology
Read more
Yannick Hoyos Mallecot

Yannick Hoyos Mallecot

Postdoctoral researcher
Microbiology
Read more
Génesis Martín Fernández

Génesis Martín Fernández

Research technician
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.